Jarrett Jennifer — SEC insider filings

SEC reporting owner CIK 1671311. 55 insider filings on record with FilingPulse; latest filed 2026-09-28.

Transaction summary — filings shown

Covers the 50 most recent of 55 filings on record, filed 2021-06-15 to 2026-09-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Arcus Biosciences, Inc. (RCUS)Chief Operating Officer31—42 legs · 484,237 sh · $11,445,25622
Damora Therapeutics, Inc. (DMRA)Director, President and CEO, Director21 leg · 12,500 sh · $252,875—2
ARENA PHARMACEUTICALS INC (ARNA)Director2——10
Syndax Pharmaceuticals Inc (SNDX)Director5——5
Zura Bio Ltd (ZURA)Director4——4
Sagimet Biosciences Inc. (SGMT)Director3——3
Radius Health, Inc. (RDUS)Director2——2
Surrozen, Inc./DE (SRZN)—1——2

Insider filings — Jarrett Jennifer

FiledFormIssuerReported transactionsSource
2026-09-284Damora Therapeutics, Inc. (DMRA)Purchase (P): 12,500 @ $20.23EDGAR
2026-06-224Zura Bio Ltd (ZURA)Grant/award (A): 51,000 (derivative) @ $0EDGAR
2026-06-154Sagimet Biosciences Inc. (SGMT)Grant/award (A): 39,567 (derivative) @ $0EDGAR
2026-04-014Damora Therapeutics, Inc. (DMRA)Grant/award (A): 500,000 @ $0 · Grant/award (A): 1,500,000 (derivative) @ $0EDGAR
2026-02-064Syndax Pharmaceuticals Inc (SNDX)Grant/award (A): 24,000 @ $0EDGAR
2026-01-264Arcus Biosciences, Inc. (RCUS)Grant/award (A): 31,000 @ $0 · Grant/award (A): 126,000 (derivative) @ $0EDGAR
2025-12-184Arcus Biosciences, Inc. (RCUS)Sale (S): 11,225 @ $21.88 · Sale (S): 9,983 @ $22.16EDGAR
2025-11-124Arcus Biosciences, Inc. (RCUS)Option exercise (M): 50,291 @ $1.23 · Sale (S): 50,291 @ $18.97 · Option exercise (M): 50,291 (derivative) @ $1.23EDGAR
2025-10-084Arcus Biosciences, Inc. (RCUS)Option exercise (M): 12,500 @ $1.23 · Sale (S): 12,500 @ $14.54 · Option exercise (M): 37,792 @ $1.23 · Sale (S): 37,792 @ $15.05 · Option exercise (M): 12,500 (derivative) @ $0 · Option exercise (M): 37,792 (derivative) @ $0EDGAR
2025-06-104Sagimet Biosciences Inc. (SGMT)Grant/award (A): 27,268 (derivative) @ $0EDGAR
2025-05-224Zura Bio Ltd (ZURA)Grant/award (A): 51,000 (derivative) @ $0EDGAR
2025-02-074Syndax Pharmaceuticals Inc (SNDX)Grant/award (A): 25,000 @ $0EDGAR
2025-01-274Arcus Biosciences, Inc. (RCUS)Grant/award (A): 50,000 @ $0 · Grant/award (A): 200,000 (derivative) @ $0EDGAR
2024-12-174Arcus Biosciences, Inc. (RCUS)Tax withholding (F): 27,501 @ $16.08EDGAR
2024-12-114Zura Bio Ltd (ZURA)Grant/award (A): 117,000 (derivative) @ $0EDGAR
2024-09-174Arcus Biosciences, Inc. (RCUS)Tax withholding (F): 12,670 @ $17.95EDGAR
2024-08-054Sagimet Biosciences Inc. (SGMT)Grant/award (A): 113,895 (derivative) @ $0EDGAR
2024-06-184Arcus Biosciences, Inc. (RCUS)Tax withholding (F): 12,670 @ $16.97EDGAR
2024-03-294Arcus Biosciences, Inc. (RCUS)Sale (S): 11,551 @ $17.55EDGAR
2024-03-204Arcus Biosciences, Inc. (RCUS)Sale (S): 12,153 @ $17.84 · Sale (S): 1,296 @ $18.62EDGAR
2024-02-284Arcus Biosciences, Inc. (RCUS)Sale (S): 24,555 @ $20.07 · Sale (S): 34,070 @ $20.11EDGAR
2024-02-094Syndax Pharmaceuticals Inc (SNDX)Grant/award (A): 17,000 @ $0EDGAR
2024-01-254Arcus Biosciences, Inc. (RCUS)Grant/award (A): 40,000 @ $0 · Grant/award (A): 162,400 (derivative) @ $0EDGAR
2023-12-264Arcus Biosciences, Inc. (RCUS)Sale (S): 21,521 @ $17.76EDGAR
2023-12-204Arcus Biosciences, Inc. (RCUS)Disposition to issuer (D): 11,250 @ $17.74 · Disposition to issuer (D): 11,492 @ $18.09EDGAR
2023-09-264Arcus Biosciences, Inc. (RCUS)Sale (S): 21,369 @ $19.99EDGAR
2023-09-204Arcus Biosciences, Inc. (RCUS)Disposition to issuer (D): 12,506 @ $20.40EDGAR
2023-07-314Arcus Biosciences, Inc. (RCUS)Sale (S): 45,000 @ $20.25EDGAR
2023-06-264Arcus Biosciences, Inc. (RCUS)Sale (S): 12,437 @ $19.12EDGAR
2023-06-164Arcus Biosciences, Inc. (RCUS)Sale (S): 12,563 @ $19.35EDGAR
2023-05-224Zura Bio Ltd (ZURA)Grant/award (A): 7,652 (derivative) @ $0EDGAR
2023-03-204Arcus Biosciences, Inc. (RCUS)Sale (S): 8,729 @ $16.81EDGAR
2023-02-034Syndax Pharmaceuticals Inc (SNDX)Grant/award (A): 16,000 @ $0EDGAR
2023-01-304Arcus Biosciences, Inc. (RCUS)Sale (S): 300 @ $23.56 · Sale (S): 1,600 @ $23.52EDGAR
2023-01-254Arcus Biosciences, Inc. (RCUS)Grant/award (A): 45,800 @ $0 · Grant/award (A): 185,900 (derivative) @ $0EDGAR
2022-12-164Arcus Biosciences, Inc. (RCUS)Sale (S): 13,879 @ $30.66 · Sale (S): 2,603 @ $31.23EDGAR
2022-09-204Arcus Biosciences, Inc. (RCUS)Sale (S): 12,677 @ $26.28EDGAR
2022-08-154Radius Health, Inc. (RDUS)Disposition to issuer (D): 30,000 (derivative) @ $4.16EDGAR
2022-06-214Arcus Biosciences, Inc. (RCUS)Sale (S): 6,081 @ $20.72 · Sale (S): 1,951 @ $21.71 · Sale (S): 4,663 @ $22.29EDGAR
2022-05-204Radius Health, Inc. (RDUS)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2022-03-184Arcus Biosciences, Inc. (RCUS)Sale (S): 9,617 @ $31.62EDGAR
2022-03-114ARENA PHARMACEUTICALS INC (ARNA)Other (J): 8,150 · Other (J): 3,067 · Disposition to issuer (D): 7,500 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · +2 moreEDGAR
2022-03-104Arcus Biosciences, Inc. (RCUS)Grant/award (A): 31,250 @ $0 · Grant/award (A): 125,000 (derivative) @ $0EDGAR
2022-02-034Syndax Pharmaceuticals Inc (SNDX)Grant/award (A): 16,000 @ $0EDGAR
2021-12-224Arcus Biosciences, Inc. (RCUS)Sale (S): 11,099 @ $40.88 · Sale (S): 20,923 @ $41.70 · Sale (S): 2,800 @ $42.23EDGAR
2021-12-204Arcus Biosciences, Inc. (RCUS)Sale (S): 4,064 @ $39.59 · Sale (S): 1,496 @ $40.46 · Sale (S): 1,580 @ $38.79 · Sale (S): 1,008 @ $39.67 · Sale (S): 1,955 @ $40.57 · Sale (S): 2,575 @ $41.42EDGAR
2021-09-224Arcus Biosciences, Inc. (RCUS)Sale (S): 8,134 @ $35.48 · Sale (S): 21,900 @ $35.06 · Sale (S): 600 @ $35.67 · Sale (S): 11,981 @ $35.50 · Sale (S): 4,885 @ $35.98EDGAR
2021-08-134Surrozen, Inc./DE (SRZN)Grant/award (A): 30,000 · Disposition to issuer (D): 30,000 (derivative) @ $0EDGAR
2021-06-214Arcus Biosciences, Inc. (RCUS)Sale (S): 3,809 @ $24.13 · Sale (S): 159 @ $24.77 · Sale (S): 4,863 @ $23.68EDGAR
2021-06-154ARENA PHARMACEUTICALS INC (ARNA)Grant/award (A): 3,067 @ $0 · Grant/award (A): 7,202 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1671311 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs